Search results
Added:
1 year ago
In this programme, a leading faculty delve into the groundbreaking advancements in the treatment of severe tricuspid regurgitation with the innovative EdwardsEVOQUE Tricuspid Valve Replacement System. This session features an informative "Live in a Box" transcatheter tricuspid replacement valve case by Prof Jörg Hausleiter. It provides a comprehensive analysis of the patient selection criteria,…
View more
Added:
7 months ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter tricuspid valve replacement (TTVR) compared to optimal medical therapy for patients with severe tricuspid regurgitation (TR).Dr Susheel Kodali (Columbia University Medical Center, New York, US) joins us onsite at TCT Conference to discuss the findings from the TRISCEND II Trial (NCT04482062; Edwards Lifesciences).TRISCEND II is a…
View more
Start date:
Apr 18, 2024
Added:
9 months ago
Learn from your interventional, imaging and heart failure colleagues about the latest in recognizing and treating patients with mitral and tricuspid valve disease. Explore case-based discussions, brush up on the latest clinical data and guidelines and learn more about new approved technologies for your valvular disease patients.
View more
Added:
4 weeks ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating…
View more
Added:
7 months ago
Start date:
Aug 06, 2025
Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday…
View more
Added:
1 month ago
EuroPCR25 - Two-year data confirms sustained benefits of TriClip for severe tricuspid regurgitation.We are joined by Dr Gagan Singh (UC Davis Medical Center, Sacramento, CA, US) to discuss key findings from the TRILUMINATE pivotal trial. This randomised controlled trial compared the TriClip device against medical therapy in symptomatic patients with severe tricuspid regurgitation (TR) who are at…
View more
Added:
1 month ago
EuroPCR 2025 - Outcomes from the FATE Registry show coapttion gaps are at the upper limit of treatability in this patient group using current tTEER devices.Dr Fedrico de Marco (Centro Cardiologico Monzino IRCCS, Milan, IT) joins us to discuss the management and outcomes from the FATE registry, which investigated 123 case of failed tricuspid transcatheter edge-to-edge repair (tTEER) with all…
View more
Added:
4 weeks ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement…
View more
